Literature DB >> 29428135

When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion?

Sana M Al-Khatib1, Daniel J Friedman2, Gillian D Sanders2.   

Abstract

The implantable cardioverter defibrillator (ICD) is a life-saving therapy in various patient populations. Although data on the outcomes of initial ICD implants are abundant, data on ICD replacements, especially in patients with improved left ventricular (LV) function, are scarce. Therefore, it is not known when it is safe to not replace an ICD that has reached the end of battery life. This article reviews data on patients with primary prevention ICDs who have improvement in left ventricular ejection fraction during follow-up and provides some guidance, based on the available evidence, related to circumstances when replacement of an ICD may be forgone.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Implantable cardioverter defibrillator; Left ventricular ejection fraction recovery; Sudden cardiac death

Mesh：

Year:  2018        PMID： 29428135      PMCID： PMC6861160          DOI： 10.1016/j.ccep.2017.11.014

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN： 1877-9182


  42 in total

1.  Time for a change--a new approach to ICD replacement.

Authors:  Daniel B Kramer; Alfred E Buxton; Peter J Zimetbaum
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

2.  Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.

Authors:  Jeanne E Poole; Marye J Gleva; Theofanie Mela; Mina K Chung; Daniel Z Uslan; Richard Borge; Venkateshwar Gottipaty; Timothy Shinn; Dan Dan; Leon A Feldman; Hanscy Seide; Stuart A Winston; John J Gallagher; Jonathan J Langberg; Kevin Mitchell; Richard Holcomb
Journal:  Circulation       Date:  2010-10-04       Impact factor: 29.690

3.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Circulation       Date:  2012-12-19       Impact factor: 29.690

Review 4.  The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.

Authors:  Mark S Kremers; Stephen C Hammill; Charles I Berul; Christina Koutras; Jeptha S Curtis; Yongfei Wang; Jim Beachy; Laura Blum Meisnere; Del M Conyers; Matthew R Reynolds; Paul A Heidenreich; Sana M Al-Khatib; Ileana L Pina; Kathleen Blake; Mary Norine Walsh; Bruce L Wilkoff; Alaa Shalaby; Frederick A Masoudi; John Rumsfeld
Journal:  Heart Rhythm       Date:  2013-02-09       Impact factor: 6.343

5.  Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Authors:  Jagmeet P Singh; W Jackson Hall; Scott McNitt; Hongyue Wang; James P Daubert; Wojciech Zareba; Jeremy N Ruskin; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

6.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

7.  Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.

Authors:  Nick Van Boven; Kjell Bogaard; Jaap Ruiter; Geert Kimman; Dominic Theuns; Isabella Kardys; Victor Umans
Journal:  J Cardiovasc Electrophysiol       Date:  2012-12-04

8.  Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.

Authors:  Yiyi Zhang; Eliseo Guallar; Elena Blasco-Colmenares; Barbara Butcher; Sanaz Norgard; Victor Nauffal; Joseph E Marine; Zayd Eldadah; Timm Dickfeld; Kenneth A Ellenbogen; Gordon F Tomaselli; Alan Cheng
Journal:  J Am Coll Cardiol       Date:  2015-08-04       Impact factor: 24.094

9.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Authors:  Cecilia Linde; William T Abraham; Michael R Gold; Martin St John Sutton; Stefano Ghio; Claude Daubert
Journal:  J Am Coll Cardiol       Date:  2008-11-07       Impact factor: 24.094

Review 10.  Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.

Authors:  Neal A Chatterjee; Attila Roka; Steven A Lubitz; Michael R Gold; Claude Daubert; Cecilia Linde; Jan Steffel; Jagmeet P Singh; Theofanie Mela
Journal:  Eur Heart J       Date:  2015-08-10       Impact factor: 29.983
View more
  1 in total

1.  Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes.

Authors:  Kenneth C Bilchick; Yongfei Wang; Jeptha P Curtis; Ramin Shadman; Todd F Dardas; Inder Anand; Lars H Lund; Ulf Dahlström; Ulrik Sartipy; Wayne C Levy
Journal:  J Am Heart Assoc       Date:  2022-06-29       Impact factor: 6.106
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.